Dr. Lalan Wilfong, MD

Medical Oncology Dallas, TX Male
NPI: 1497793509
Total Payments
$47,735
2024 Payments
$17,885
Companies
20
Transactions
71
Medicare Patients
1,011
Medicare Billing
$137,620

Payment Breakdown by Category

Consulting$29,425 (61.6%)
Other$9,300 (19.5%)
Travel$7,821 (16.4%)
Food & Beverage$1,189 (2.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $29,425 11 61.6%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $9,003 3 18.9%
Travel and Lodging $7,821 24 16.4%
Food and Beverage $1,189 32 2.5%
Compensation for serving as faculty or as a speaker for a medical education program $297.39 1 0.6%

Top Paying Companies

Company Total Records Latest Year
PFIZER INC. $25,737 28 $0 (2024)
GENZYME CORPORATION $6,207 3 $0 (2021)
Janssen Scientific Affairs, LLC $5,902 3 $0 (2024)
Genentech USA, Inc. $5,756 7 $0 (2018)
ABBVIE INC. $2,888 2 $0 (2022)
AstraZeneca Pharmaceuticals LP $549.93 5 $0 (2024)
E.R. Squibb & Sons, L.L.C. $194.86 6 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $110.11 1 $0 (2024)
Novartis Pharmaceuticals Corporation $81.51 2 $0 (2023)
Tempus AI, Inc $74.47 3 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $17,885 23 PFIZER INC. ($11,364)
2023 $110.31 5 Kite Pharma, Inc. ($28.63)
2022 $3,172 9 ABBVIE INC. ($2,888)
2021 $6,125 1 GENZYME CORPORATION ($6,125)
2020 $7,809 7 PFIZER INC. ($7,809)
2019 $4,719 10 PFIZER INC. ($4,476)
2018 $7,842 14 Genentech USA, Inc. ($5,756)
2017 $74.17 2 PFIZER INC. ($74.17)

All Payment Transactions

71 individual payment records from CMS Open Payments — Page 3 of 3

Date Company Product Nature Form Amount Type
03/21/2019 GENZYME CORPORATION NO PRODUCT DISCUSSED (Drug) Travel and Lodging In-kind items and services $45.44 General
03/21/2019 GENZYME CORPORATION NO PRODUCT DISCUSSED (Drug) Travel and Lodging In-kind items and services $36.53 General
02/21/2019 E.R. Squibb & Sons, L.L.C. — Travel and Lodging Cash or cash equivalent $75.73 General
02/14/2019 PFIZER INC. — Travel and Lodging In-kind items and services $230.72 General
01/28/2019 PFIZER INC. — Consulting Fee Cash or cash equivalent $3,500.00 General
12/11/2018 PFIZER INC. — Travel and Lodging In-kind items and services $1,071.88 General
12/11/2018 PFIZER INC. — Travel and Lodging In-kind items and services $636.34 General
12/11/2018 PFIZER INC. — Travel and Lodging In-kind items and services $290.60 General
11/19/2018 PFIZER INC. RETACRIT (Biological) Food and Beverage In-kind items and services $3.60 General
Category: HEMATOLOGY
05/22/2018 INSYS Therapeutics Inc SYNDROS (Drug) Food and Beverage In-kind items and services $15.86 General
Category: Chemotherapy-Induced Nausea and Vomiting
05/09/2018 Genentech USA, Inc. — Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,125.00 General
05/09/2018 Genentech USA, Inc. — Travel and Lodging Cash or cash equivalent $1,030.44 General
05/09/2018 Genentech USA, Inc. — Travel and Lodging Cash or cash equivalent $291.58 General
05/09/2018 Genentech USA, Inc. — Food and Beverage In-kind items and services $104.84 General
05/09/2018 Genentech USA, Inc. — Food and Beverage In-kind items and services $83.81 General
05/09/2018 Genentech USA, Inc. — Travel and Lodging Cash or cash equivalent $83.36 General
05/09/2018 Genentech USA, Inc. — Food and Beverage Cash or cash equivalent $36.71 General
04/10/2018 MEDIVATION FIELD SOLUTIONS LLC XTANDI (Drug) Food and Beverage In-kind items and services $11.54 General
Category: ONCOLOGY
03/02/2018 Novartis Pharmaceuticals Corporation — Food and Beverage In-kind items and services $56.03 General
04/27/2017 PFIZER INC. — Travel and Lodging In-kind items and services $44.42 General
04/27/2017 PFIZER INC. — Food and Beverage In-kind items and services $29.75 General
«123

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 16 349 13,724 $251,647 $47,340
2022 11 271 3,588 $253,844 $62,880
2021 6 152 351 $39,144 $18,529
2020 9 239 468 $44,656 $8,871
Total Patients
1,011
Total Services
18,131
Medicare Billing
$137,620
Procedure Codes
42

All Medicare Procedures & Services

42 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
J0897 Injection, denosumab, 1 mg Office 2023 11 1,260 $82,680 $23,378 28.3%
96413 Administration of chemotherapy into vein, 1 hour or less Office 2023 15 49 $34,643 $4,824 13.9%
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Office 2023 16 11,220 $56,100 $4,310 7.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 33 62 $15,500 $3,855 24.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 23 37 $13,616 $3,101 22.8%
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less Office 2023 18 95 $14,915 $2,037 13.7%
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less Office 2023 24 35 $10,955 $1,623 14.8%
36415 Insertion of needle into vein for collection of blood sample Office 2023 43 139 $2,780 $1,168 42.0%
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count Office 2023 44 113 $4,068 $847.00 20.8%
96372 Injection of drug or substance under skin or into muscle Office 2023 23 60 $5,760 $635.43 11.0%
80053 Blood test, comprehensive group of blood chemicals Office 2023 28 60 $3,840 $612.61 16.0%
96375 Injection of additional new drug or substance into vein Office 2023 13 39 $4,212 $444.18 10.5%
82728 Ferritin (blood protein) level Office 2023 13 17 $1,020 $215.25 21.1%
83550 Iron binding capacity Office 2023 13 17 $595.00 $138.07 23.2%
83540 Iron level Office 2023 13 17 $459.00 $102.15 22.3%
J1100 Injection, dexamethasone sodium phosphate, 1 mg Office 2023 19 504 $504.00 $49.27 9.8%
J0897 Injection, denosumab, 1 mg Office 2022 12 2,520 $147,240 $43,185 29.3%
96413 Administration of chemotherapy into vein, 1 hour or less Office 2022 12 42 $29,694 $4,424 14.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 25 48 $17,664 $3,930 22.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 44 64 $16,000 $3,789 23.7%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 14 21 $10,416 $2,741 26.3%
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less Office 2022 14 61 $9,577 $1,417 14.8%
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less Office 2022 15 25 $7,825 $1,197 15.3%
96372 Injection of drug or substance under skin or into muscle Office 2022 20 92 $8,832 $1,019 11.5%
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count Office 2022 51 98 $3,528 $751.22 21.3%
12»

About Dr. Lalan Wilfong, MD

Dr. Lalan Wilfong, MD is a Medical Oncology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497793509.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lalan Wilfong, MD has received a total of $47,735 in payments from pharmaceutical and medical device companies, with $17,885 received in 2024. These payments were reported across 71 transactions from 20 companies. The most common payment nature is "Consulting Fee" ($29,425).

As a Medicare-enrolled provider, Wilfong has provided services to 1,011 Medicare beneficiaries, totaling 18,131 services with total Medicare billing of $137,620. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.

Practice Information

  • Specialty Medical Oncology
  • Other Specialties Hematology & Oncology
  • Location Dallas, TX
  • Active Since 06/02/2006
  • Last Updated 04/07/2009
  • Taxonomy Code 207RX0202X
  • Entity Type Individual
  • NPI Number 1497793509

Products in Payments

  • ELREXFIO (Drug) $9,465
  • VENCLEXTA (Drug) $2,750
  • NO PRODUCT DISCUSSED (Drug) $81.97
  • XT CDX (Device) $74.47
  • Trodelvy (Drug) $40.06
  • SIR-Spheres Microspheres (Device) $33.15
  • LUTATHERA (Drug) $25.48
  • PADCEV (Biological) $25.30
  • INJECTAFER (Drug) $24.48
  • EPKINLY (Drug) $22.51
  • KEYTRUDA (Biological) $20.93
  • NERLYNX (Drug) $19.46
  • Lenvima (Drug) $17.52
  • SYNDROS (Drug) $15.86
  • OPDIVO (Biological) $13.50
  • BOSULIF (Drug) $12.76
  • XTANDI (Drug) $11.54
  • ELIQUIS (Drug) $11.49
  • RETACRIT (Biological) $3.60

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Medical Oncology Doctors in Dallas

Dr. Moshe Levy, Md, MD

Medical Oncology — Payments: $5.0M

Medical Oncology $5.0M

Dr. Eric Nadler, Md, MD

Medical Oncology — Payments: $1.8M

Medical Oncology $1.8M

Dr. Joyce O'shaughnessy, Md, MD

Medical Oncology — Payments: $1.6M

Medical Oncology $1.6M

Dr. Thomas Hutson, Do,Pharmd, DO,PHARMD

Medical Oncology — Payments: $1.3M

Medical Oncology $1.3M

Dr. Tian Zhang, M.d, M.D

Medical Oncology — Payments: $395,066

Medical Oncology $395,066

Dr. Ashwani Agarwal, M.d, M.D

Medical Oncology — Payments: $304,262

Medical Oncology $304,262